Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NQO1 | P15559 | 1/20 | 0.62 |
| ▸ | CA12 | O43570 | 2/20 | 0.60 |
| ▸ | CA1 | P00915 | 2/20 | 0.60 |
| ▸ | CA9 | Q16790 | 2/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | MAOA | P21397 | 2/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.50 |
| ▸ | CASP1 | P29466 | 1/20 | 0.50 |
| ▸ | CASP7 | P55210 | 1/20 | 0.50 |
| ▸ | PRKDC | P78527 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5396825 | 0.78 | NQO1 (0.67) | NQO1CA12CA1CA9ALDH1A1 | |
| SCHEMBL5538005 | 0.77 | NQO1 (0.64) | NQO1CA12CA1CA9ALDH1A1 | |
| SCHEMBL4396062 | 0.77 | NQO1 (1.00) | NQO1CA12CA1CA9ALDH1A1 | |
| SCHEMBL28661113 | 0.76 | PRKDC (0.40) | NQO1CA12CA1CA9ALDH1A1 | |
| SCHEMBL23747123 | 0.75 | NQO1 (0.62) | NQO1CA12CA1CA9ALDH1A1 | |
| SCHEMBL66891 | 0.75 | MAOA (0.74) | NQO1CA12CA1CA9ALDH1A1 | |
| SCHEMBL21645358 | 0.75 | NQO1 (0.62) | NQO1CA12CA1CA9ALDH1A1 | |
| 4-Hydroxycoumarins SCHEMBL131312 | 0.75 | CA12 (1.00) | NQO1CA12CA1CA9ALDH1A1 | |
| SCHEMBL5670266 | 0.75 | NQO1 (0.62) | NQO1CA12CA1CA9ALDH1A1 | |
| SCHEMBL3547598 | 0.75 | NQO1 (0.62) | NQO1CA12CA1CA9ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 326 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024146839-A1 | PHOTOCAGED CAP ANALOGS FOR THE 5'-END OF RNAS | Westfälische Wilhelms-Universität Münster (DE) | 2024-07-11 | — | — | WO | claimed |
| EP-4397669-A1 | PHOTOCAGED CAP ANALOGS FOR THE 5'-END OF RNAS | Westfälische Wilhelms-Universität Münster (DE) | 2024-07-10 | — | — | EP | claimed |
| US-11993801-B2 | Base-modified nucleotides as substrates for TdT-based enzymatic nucleic acid synthesis | ILLUMINA SINGAPORE PTE. LTD. (SG) | 2024-05-28 | — | — | US | claimed |
| US-11897977-B2 | Photolabile barbiturate compounds | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2024-02-13 | — | — | US | claimed |
| WO-2023119007-A1 | ARTICLES HAVING A COATING INCLUDING POLYELECTROLYTES AND A PHOTOCLEAVABLE POLYMER, AND METHODS OF MAKING SAME | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-06-29 | — | — | WO | claimed |
| EP-4185707-A1 | BASE-MODIFIED NUCLEOTIDES AS SUBSTRATES FOR TDT-BASED ENZYMATIC NUCLEIC ACID | Illumina Singapore Pte Ltd (SG) | 2023-05-31 | — | — | EP | claimed |
| CN-115867670-A | Base-modified nucleotides as substrates for TDT-based enzyme nucleic acids | 伊鲁米纳新加坡有限公司 | 2023-03-28 | — | — | CN | claimed |
| US-11370940-B2 | Adhesive article and methods of making and using the same | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2022-06-28 | — | — | US | claimed |
| EP-3746489-B1 | PHOTOLABILE BARBITURATE COMPOUNDS | 3M INNOVATIVE PROPERTIES CO (US) | 2022-03-30 | — | — | EP | claimed |
| US-20220025421-A1 | BASE-MODIFIED NUCLEOTIDES AS SUBSTRATES FOR TDT-BASED ENZYMATIC NUCLEIC ACID SYNTHESIS | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2022-01-27 | — | — | US | claimed |
| EP-3316910-A1 | TRIPLET-TRIPLET ANNIHILATION-BASED UPCONVERSION | Children's Medical Center Corporation (US) | 2018-05-09 | — | — | EP | claimed |
| US-20180021460-A1 | PROBES AND METHODS FOR DETECTING AMYLOIDOGENIC PROTEINS | ACADEMIA SINICA (TW) | 2018-01-25 | — | — | US | claimed |
| WO-2017095704-A1 | REDOX POLYMERIZABLE COMPOSITION WITH PHOTOLABILE REDUCING AGENTS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2017-06-08 | — | — | WO | claimed |
| WO-2017079189-A1 | REDOX POLYMERIZABLE DENTAL COMPOSITION WITH PHOTOLABILE TRANSITION METAL COMPLEXES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2017-05-11 | — | — | WO | claimed |
| WO-2017078883-A1 | REDOX POLYMERIZABLE COMPOSITION WITH PHOTOLABILE TRANSITION METAL COMPLEXES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2017-05-11 | — | — | WO | claimed |
| WO-2017004310-A1 | TRIPLET-TRIPLET ANNIHILATION-BASED UPCONVERSION | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2017-01-05 | — | — | WO | claimed |
| US-20150148243-A1 | METHOD FOR REVERSIBLE FIXATION OR SELECTIVE LYSIS OF CELL USING PHOTOCLEAVABLE POLYMER | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-05-28 | — | — | US | claimed |
| EP-0853628-B1 | PHOTOLABILE 8-SUBSTITUTED CYCLIC NUCLEOTIDE ESTERS, METHODS OF PREPARING THEM AND THEIR USE | FORSCHUNGSVERBUND BERLIN EV (DE) | 2002-10-02 | — | — | EP | claimed |
| EP-0853628-A1 | PHOTOLABILE 8-SUBSTITUTED CYCLIC NUCLEOTIDE ESTERS, METHODS OF PREPARING THEM AND THEIR USE | Forschungsverbund Berlin e.V. (DE) | 1998-07-22 | — | — | EP | claimed |
| WO-1997005155-A1 | PHOTOLABILE 8-SUBSTITUTED CYCLIC NUCLEOTIDE ESTERS, METHODS OF PREPARING THEM AND THEIR USE | FORSCHUNGSVERBUND BERLIN E.V. (DE) | 1997-02-13 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11897977-B2 | Photolabile barbiturate compounds | PPOX, CBR1, CBR3 | NQO1 103/4885CA12 3722/4885CA1 1575/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.